Skip to main content
Kunal Kadakia, MD, Oncology, Charlotte, NC

Kunal C Kadakia MD

Oncology•Charlotte, NC

Gastrointestinal Cancer, Hospice & Palliative

Associate Professor, Department of Cancer Medicine, Wake Forest University School of Medicine, Gastrointestinal Medical Oncology and Supportive Oncology, Section Chief of Oncology Nutrition and Research, Department of Supportive Oncology, Atrium Health Wake Forest Comprehensive Cancer Center

Join to view full profile

  • 1021 Morehead Medical DrSte ACharlotte, NC 28204

  • Phone+1 980-442-2000

Dr. Kadakia is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Kadakia's full profileAlready have an account?

Education & Training

  • University of Michigan
    University of MichiganFellowship, Hematology and Medical Oncology, 2013 - 2016
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Hospice and Palliative Medicine, 2012 - 2013
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
  • Northeast Ohio Medical University
    Northeast Ohio Medical UniversityClass of 2009

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2016 - 2027
  • MI State Medical License
    MI State Medical License 2013 - 2017
  • OH State Medical License
    OH State Medical License 2014 - 2016
  • TX State Medical License
    TX State Medical License 2012 - 2014
  • MN State Medical License
    MN State Medical License 2010 - 2012
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Hospice and Palliative Medicine
    American Board of Internal Medicine Hospice and Palliative Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Honorary Co-Chair Pancreatic Cancer Action Network, PurpleStride Charlotte, NC, 2018
  • Next Gen Innovator HemOnc Today, 2018
  • Fellow of the American College of Physicians American College of Physicians, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Commentary on A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast ...  
    Kadakia K.C., Henry, N.L., . Breast Diseases: A Year Book Quarterly., 11/2014

Books/Book Chapters

  • Oncology Board Review: Blueprint Study Guide and Q&A; Demos Medical Publishing, New York, NY, 2017. 
    Chapter: Breast Cancer 
    Page 188 - 205Kadakia KC, Cobain E, Burness MLEditors: Worden FP, Khoriaty RN, Cobain E, Pearson AT. Demos Medical Publishing, New YornEdition 2nd,2017
  • Internal Medicine Issues in Palliative Cancer Care 
    Chapter: Hyperthyroidism 
    Kadakia, K.C., Dev, R.Editors: Hui, D and Bruera, E..Oxford University PressEdition 1,
  • Tumor Board Review: Guidelines and Case Reviews in Oncology 
    Chapter: Non-small Cell Lung Cancer 
    Kadakia, K.C., Ramnath, N.Editors: Todd, T.F., Cooney, K.A., Hayes, T., Mims, M.P., and Worden F.P..Demos Medical PublishingEdition 2nd,

Abstracts/Posters

  • Nintedanib in metastatic appendiceal carcinoma
    1. Birendra KC, Ahmad MN, Kadakia KC, Nazemzadeh R, Salem ME, Chai S, Salmon JS, Symanowski JT, Boselli D, Hwang JJ, 2019 Gastrointestinal Cancers Symposium, San Francisco, CA, 1/19/2019
  • Examination of factors that influence use of extended adjuvant endocrine therapy (ET).
    Kadakia KC, Kidwell KM, Barton DL, Griggs J, Henry NL, 2017 ASCO Annual Meeting; (suppl; abstr e21618), Chicago, IL, 4/3/2017
  • Crossover from one aromatase inhibitor (AI) to another in the Exemestane (E) and Letrozole (L) Pharmacogenetics (ELPh) trial.
    Kadakia KC, Kidwell KM, Stearns V, Hayes DF, Henry NL, et. al., ASCO Cancer Survivorship Symposium: Advancing Care and Research – A Primary Care and Oncology Symposium, San Francisco, CA, 1/16/2016

Lectures

  • An institutional series of early-onset pancreatic cancer (EOPC): Clinical outcomes and genetic and supportive care referral patterns. 
    ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020

Committees

  • Levine Cancer Institute, Hematology and Oncology Fellowship Program, Fellowship Program Evaluation Committee Member 2018 - Present
  • Levine Cancer Institute, Charlotte, NC, Data Safety Monitoring Board (DSMB), Member 2017 - Present
  • Member, House Officer Quality & Safety Council 2015 - 2016

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Kunal Kadakia, Dr. Kunal Kadakia, MD, Dr. K Kadakia, Dr. Kunal C Kadakia